Loss of fructose-1,6-bisphosphatase (FBP1), a rate limiting enzyme in gluconeogenesis, was found to be oncogenic in various cancer cells including gastric and colon cancer cells, suggesting that modulation of gluconeogenesis also plays an equal role in tumorigenesis [46,47]. This evidence concerns the gene FBP1 and malignant colon neoplasm.